Global Nuclear Medicine Market Analysis, Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

  • TBI385275
  • August 01, 2019
  • Global
  • 132 pages
  • HCCResearch
                                          

Abstract, Snapshot, Market Analysis & Market Definition: Global Nuclear Medicine Market

The global Nuclear Medicine market size is projected to reach US$ 16.75 billion by 2026, from US$ 9.4 billion in 2020, at a CAGR of 10.1% during 2021-2026. Need for early and accurate diagnostic methods, coupled with growing demand for better therapies, is driving the market. Increasing incidence of cancer and cardiovascular disorders is also contributing toward market growth as nuclear medicine has proven rather accurate in the diagnosis and treatment of such conditions. According to the World Health Organization (WHO) in February 2015, the number of new cases of cancer is expected to grow by around 70% over the next two decades. Globally, 8.8 million people died from cancer in 2015. Cancer accounts for one out of every six deaths globally. Increasing prevalence of cardiovascular diseases is fueling market growth. These diseases accounted for more than 17.7 million deaths in 2015 globally. The number is anticipated to cross around 23 million by 2030. An estimated 31.0% of global deaths can be attributed to cardiovascular diseases. Presently, radiopharmaceuticals are widely used in the field of oncology and cardiovascular diseases. Ongoing research and studies demonstrating positive results is widening the scope of radioisotope applications for diagnosis and treatment of bone diseases, respiratory diseases, thyroid-related diseases, and conditions of the digestive tract. Along with these applications, radioisotopes are largely used in radiopharmacology to study drug movement in lab subjects.

Market Segmentation, Outlook & Viewpoint: Global Nuclear Medicine Market

Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Diagnostics

  • SPECT
  • TC-99m
  • TL-201
  • GA-67
  • I-123
  • Others
  • PET
  • F-18
  • RB-82
  • Others

Therapeutics

  • Alpha Emitters
  • RA-223
  • Others
  • Beta Emitters
  • I-131
  • Y-90
  • SM-153
  • Re-186
  • Lu-117
  • Others

Brachytherapy

  • Cesium-131
  • Iodine-125
  • Palladium-103
  • Iridium-192
  • Others

Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  • Diagnostics
  • Cardiology
  • Neurology
  • Oncology
  • Thyroid
  • Lymphoma
  • Others
  • Therapeutics
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumor
  • Others

Key Players, Recent Developments & Regional Insights: Global Nuclear Medicine Market

Ability to integrate with other diagnostic techniques such as x-ray is anticipated to boost the growth of diagnostic products. Based on product, the biopharmaceuticals market is bifurcated into diagnostic and therapeutic. The diagnostic segment, which includes Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), held the dominant share in 2016. The therapeutics segment, which comprises alpha emitters, beta emitters, and brachytherapy, is poised to witness the fastest growth through 2025. SPECT was the largest diagnostic sub-segment in 2016, while PET is estimated to register a strong growth rate over the forecast period. Even though a SPECT scan is relatively cheaper than a PET scan, the latter is more advantageous than the former. The resolution offered by a PET scan is in the range of 5-7 mm while that of SPECT is 12-15 mm. The imaging time for the former is relatively longer than the former due to the prolonged half-life of tracer radioisotopes used. Beta emitters held the largest market share in 2016, while brachytherapy is estimated to exhibit the fastest growth over the forecast period. Alpha emitters enjoy the advantage of having a shorter span of radiation zone. This characteristic is very helpful in eradication of cancerous cells and minimizes the effect of radiation on healthy cells. Beta emitters have been gaining popularity in radiotherapy in the past decade owing to various associated advantages, such as effective treatment, fewer side effects, and easy administration. Brachytherapy has proven to be a good alternative for chemotherapy and surgery in cancer treatment. Advantages such as high safety profile and reduced cost are expected to boost the segment in emerging regions. Advancements in scanning technology are increasing the efficiency of diagnosis using radioisotopes, and as a result, application areas of existing radioisotopes are swiftly increasing. Widening applications of existing products, coupled with introduction of newer radioisotopes for diagnosis of respiratory-, bones-, and thyroid-related diseases, are spurring the diagnostics market.

Regional Insights

North America spearheaded the market in 2016, accounting for a share of over 44.0% that year. This can be attributed to advanced healthcare infrastructure in the region, especially in U.S. Rising burden of cancer and various cardiovascular disorders is also a high impact rendering factor driving the market. Asia Pacific is anticipated to register the highest CAGR of 10.7% during the forecast period. Demand for nuclear medicine is increasing in emerging markets such as China and India due to rising disposable income, improving healthcare standards, and favorable reforms in foreign policies. China is dominates the Asia Pacific market and is likely to hold on to its lead position through 2025.

Nuclear Medicine Market Share Insights

Key players in the market include Eckert & Ziegler Group; Mallinckrodt Pharmaceuticals; GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A; Nordion, Inc.; The Institute of Radioelements; Australian Nuclear Science & Technology Organization (ANSTO); NTP Radioisotopes SOC Ltd.; and Eczacibasi-Monrol. New product launch, collaboration, mergers and acquisitions, and regional expansion are among prominent strategic initiatives undertaken by these industry players. For instance, in August 2016, the Eckert & Ziegler Group acquired BR - 77 Comercio, Distribuidora e Transportes de Medicamentos Ltda based in Brazil. Through this acquisition, the company aims to expand its presence in South America.

Key Insights Covered: Global Nuclear Medicine Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Nuclear Medicine industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Nuclear Medicine industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Nuclear Medicine industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Nuclear Medicine industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Nuclear Medicine industry.

Research Methodology: Global Nuclear Medicine Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other

Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 List Of AbbreviationsChapter 2 Executive Summary
2.1 Market SummaryChapter 3 Market Variables, Trends & Scope
3.1 Market SegmentationChapter 4 Market DefinitionsChapter 5 Industry Outlook
5.1 Market Variable Analysis
    5.1.1 Rising Incidence Of Cancer And Cardiovascular Disease
    5.1.2 Widening Applications Of Radiopharmaceuticals
    5.1.3 Growing Demand For The Accurate Diagnostic Methods
5.2 Market Restraint Analysis
    5.2.1 Stringent Regulation For Production, Storage, An
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form